Birdwatch Note
2024-10-24 08:04:17 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
任意の有害事象報告頻度は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは因果関係推定には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 例えばわが国の副反応疑い報告でも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1です(下記74P https://www.mhlw.go.jp/content/10601000/00109164.pdf 専門家の21年6月23日の評価でも因果関係が否定できないの評価は0件ですし https://www.mhlw.go.jp/content/10601000/000796557.pdf 諸事情は違いますが新型インフルワクチンの時も2300万接種で133の死亡報告があり例年の数十倍の頻度の報告がありましたが関連はほぼ確認されていません https://www.yakuji.co.jp/entry21054.html 投稿者の考えはこうした専門機関の見解と異なる事に注意が必要です
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1849340780277878976
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1849361254777008608
- noteId - 1849361254777008608
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1729757057266
- tweetId - 1849340780277878976
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 任意の有害事象報告頻度は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは因果関係推定には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 例えばわが国の副反応疑い報告でも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1です(下記74P https://www.mhlw.go.jp/content/10601000/00109164.pdf 専門家の21年6月23日の評価でも因果関係が否定できないの評価は0件ですし https://www.mhlw.go.jp/content/10601000/000796557.pdf 諸事情は違いますが新型インフルワクチンの時も2300万接種で133の死亡報告があり例年の数十倍の頻度の報告がありましたが関連はほぼ確認されていません https://www.yakuji.co.jp/entry21054.html 投稿者の考えはこうした専門機関の見解と異なる事に注意が必要です
Note Ratings
rated at | rated by | |
2024-10-25 08:16:59 -0500 | Rating Details | |
2024-10-25 02:23:14 -0500 | Rating Details | |
2024-10-24 23:59:32 -0500 | Rating Details | |
2024-10-24 12:38:07 -0500 | Rating Details | |
2024-10-24 10:15:40 -0500 | Rating Details | |
2024-10-24 08:41:58 -0500 | Rating Details | |
2024-10-24 07:32:34 -0500 | Rating Details | |
2024-10-24 06:10:52 -0500 | Rating Details | |
2024-10-24 05:13:24 -0500 | Rating Details | |
2024-10-24 05:00:05 -0500 | Rating Details | |
2024-10-24 04:50:25 -0500 | Rating Details | |
2024-10-24 04:47:38 -0500 | Rating Details | |
2024-10-24 04:47:02 -0500 | Rating Details | |
2024-10-24 19:37:11 -0500 | Rating Details | |
2024-10-24 13:36:48 -0500 | Rating Details | |
2024-10-24 10:20:10 -0500 | Rating Details | |
2024-10-24 09:12:15 -0500 | Rating Details | |
2024-10-24 04:46:01 -0500 | Rating Details | |
2024-10-24 04:45:03 -0500 | Rating Details | |
2024-10-24 03:39:21 -0500 | Rating Details | |
2024-10-24 03:25:19 -0500 | Rating Details | |
2024-10-24 03:23:17 -0500 | Rating Details | |
2024-10-24 03:18:18 -0500 | Rating Details | |
2024-10-26 03:56:59 -0500 | Rating Details | |
2024-10-25 20:31:41 -0500 | Rating Details | |
2024-10-25 16:47:40 -0500 | Rating Details | |
2024-10-24 22:07:47 -0500 | Rating Details | |
2024-10-24 11:22:49 -0500 | Rating Details | |
2024-10-24 09:43:22 -0500 | Rating Details | |
2024-10-24 08:45:12 -0500 | Rating Details | |
2024-10-24 08:22:32 -0500 | Rating Details | |
2024-10-24 07:35:27 -0500 | Rating Details | |
2024-10-24 07:29:20 -0500 | Rating Details | |
2024-10-24 06:37:00 -0500 | Rating Details | |
2024-10-24 05:06:19 -0500 | Rating Details | |
2024-10-24 05:06:04 -0500 | Rating Details | |
2024-10-24 04:33:17 -0500 | Rating Details | |
2024-10-24 04:32:41 -0500 | Rating Details | |
2024-10-24 03:55:43 -0500 | Rating Details | |
2024-10-24 03:50:00 -0500 | Rating Details | |
2024-10-24 03:26:53 -0500 | Rating Details | |
2024-10-24 03:20:04 -0500 | Rating Details | |
2024-10-24 03:17:37 -0500 | Rating Details | |
2024-10-26 12:34:46 -0500 | Rating Details | |
2024-10-24 23:17:07 -0500 | Rating Details | |
2024-10-24 16:51:11 -0500 | Rating Details | |
2024-10-24 09:54:33 -0500 | Rating Details | |
2024-10-24 08:45:29 -0500 | Rating Details | |
2024-10-24 06:56:27 -0500 | Rating Details | |
2024-10-24 04:57:43 -0500 | Rating Details | |
2024-10-24 04:53:40 -0500 | Rating Details | |
2024-10-24 03:46:47 -0500 | Rating Details | |
2024-10-24 03:20:04 -0500 | Rating Details | |
2024-10-24 03:17:17 -0500 | Rating Details | |
2024-10-24 03:15:58 -0500 | Rating Details | |
2024-10-24 03:10:12 -0500 | Rating Details | |
2024-10-24 20:07:10 -0500 | Rating Details | |
2024-10-24 19:47:22 -0500 | Rating Details | |
2024-10-24 10:56:48 -0500 | Rating Details | |
2024-10-24 09:08:41 -0500 | Rating Details | |
2024-10-24 08:19:59 -0500 | Rating Details | |
2024-10-24 07:46:17 -0500 | Rating Details | |
2024-10-24 05:02:34 -0500 | Rating Details | |
2024-10-24 04:33:57 -0500 | Rating Details | |
2024-10-24 04:08:51 -0500 | Rating Details | |
2024-10-24 04:08:44 -0500 | Rating Details | |
2024-10-24 03:58:26 -0500 | Rating Details | |
2024-10-24 03:54:54 -0500 | Rating Details | |
2024-10-24 03:28:38 -0500 | Rating Details | |
2024-10-24 03:27:08 -0500 | Rating Details |